Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.

scientific article published on September 2002

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1029655664
P356DOI10.1038/SJ.LEU.2402552
P698PubMed publication ID12200679
P5875ResearchGate publication ID11187195

P50authorColin StewardQ42685096
P2093author name stringHancock J
Oakhill A
Klingebiel T
Niethammer D
Bader P
Handgretinger R
Kreyenberg H
Beck JF
Goulden NJ
P2860cites workMinimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia.Q40871342
Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.Q52881409
Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy.Q54016939
Bone-marrow transplantation has a limited role in prolonging second marrow remission in childhood lymphoblastic leukaemiaQ69882182
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donorsQ70051817
Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemiaQ70513279
Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 childrenQ73283122
Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapseQ73738423
Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemiaQ74171275
Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemiaQ74408930
Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual diseaseQ74456079
The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemiaQ74459338
Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probesQ77653638
Transplantation of megadoses of purified haploidentical stem cellsQ77891866
P433issue9
P921main subjectstem cell transplantationQ65592366
P304page(s)1668-1672
P577publication date2002-09-01
P1433published inLeukemiaQ6534498
P1476titleMinimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL
P478volume16